Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging

Bibliographic Details
Main Authors:	Hees Tilman A, Herzog Benjamin, Kristen Arnt, Katus Hugo A, Abdel-Aty Hassan
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance
by: Francisca Caetano, et al.
Published: (2014-05-01)

Diagnostic questions in hypertrophic cardiomyopathy: What is the significance of late gadolinium enhancement on cardiac magnetic resonance?
by: Ana G. Almeida
Published: (2014-05-01)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
by: Di Bella Gianluca, et al.
Published: (2010-04-01)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
by: Christina Doesch, et al.
Published: (2017-07-01)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
by: Ismail Tevfik F, et al.
Published: (2013-01-01)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
by: Jassal Davinder S, et al.
Published: (2008-12-01)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
by: Lopes Mário G, et al.
Published: (2010-01-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Arrhythmogenic risk of late gadolinium enhancement in patients with hypertrophic cardiomyopathy: Burden and location?
by: Mahdi Montazeri, et al.
Published: (2020-11-01)

Arrhythmogenic risk of late gadolinium enhancement in patients with hypertrophic cardiomyopathy: Burden and location?
by: Mahdi Montazeri, et al.
Published: (2020-11-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Gibson C Michael, et al.
Published: (2008-10-01)

Characteristics and clinical associations of late gadolinium enhanced cardiovascular magnetic tesonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies
by: Franke Jennifer, et al.
Published: (2013-01-01)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass Sairia, et al.
Published: (2012-02-01)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
by: Wang S, et al.
Published: (2021-03-01)

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
by: Germans Tjeerd, et al.
Published: (2010-05-01)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
by: Pedro Freitas, et al.
Published: (2019-08-01)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
by: Bhatti Sabha, et al.
Published: (2012-02-01)

Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
by: Yasuo Amano, et al.
Published: (2018-01-01)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
by: Yusuke Morita, et al.
Published: (2014-01-01)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
by: Stremmel Wolfgang, et al.
Published: (2010-08-01)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
by: Andre Florian, et al.
Published: (2013-01-01)

Detection and prevalence of myocardial infarction early and late after heart transplantation detected by late gadolinium enhanced MRI
by: Steen Henning, et al.
Published: (2012-02-01)

Comment on «Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy»
by: Ana G. Almeida
Published: (2012-11-01)

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
by: Weng-Tein Gi, MD, MSc, et al.
Published: (2020-03-01)

Myocardial fibrosis in hypertrophic cardiomyopathy
by: Patel, Vimal
Published: (2018)

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement
by: Watanabe Eri, et al.
Published: (2012-02-01)

Assessment of Myocardial Fibrosis in Hypertrophic Cardiomyopathy by Cardiac Magnetic Resonance: Modalities and Clinical Applications.
by: Carla Contaldi
Published: (2016-01-01)

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
by: Kammerer Rebekka, et al.
Published: (2013-01-01)

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
by: Macron Laurent, et al.
Published: (2013-01-01)

Myocardial bridge in a child without hypertrophic cardiomyopathy: A case report
by: Shiv Kumar Yadav
Published: (2015-02-01)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
by: Dass Sairia, et al.
Published: (2012-02-01)